Transdermal Therapy for Attention-Deficit Hyperactivity Disorder with the Methylphenidate Patch (MTS)

Transdermal technology is currently approved in the US for the administration of more than 20 medications. This current review describes the clinical research pertaining to the use of a methylphenidate patch in the treatment of attention-deficit hyperactivity disorder (ADHD) in children and adolesce...

Descripción completa

Detalles Bibliográficos
Autores principales: Findling, Robert L., Dinh, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933749/
https://www.ncbi.nlm.nih.gov/pubmed/24532028
http://dx.doi.org/10.1007/s40263-014-0141-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933749/
https://www.ncbi.nlm.nih.gov/pubmed/24532028
http://dx.doi.org/10.1007/s40263-014-0141-y

Ejemplares similares